Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Novartis
Company Monitoring Page for Novartis
latest headlines for company on cafepharma
Upcoming events – Phase III data for Chiasma and Novartis
EP Vantage
Fri, 05/17/19 - 07:23 pm
Tags:
Chiasma
,
acromegaly
,
Mycapssa
,
clinical trials
,
multiple sclerosis
,
Novartis
,
ofatumumab
Commentary: Novartis CEO: Gene therapy offers hope of cures in one treatment, but US needs new pricing and payment model
CNBC
Fri, 05/17/19 - 07:21 pm
Tags:
gene therapy
,
cancer
,
Novartis
,
Pharma CEOs
,
Vas Narasimhan
Alcon Beats Expectations Since its Split from Novartis
Medical Devices and Diagnostics Industry
Fri, 05/17/19 - 07:13 pm
Tags:
Alcon
,
earnings
,
Novartis
,
eye health
Better than CAR-T? Already prepping for a US launch, MorphoSys posts stellar DLBCL data to field against Novartis, Gilead
Endpoints
Fri, 05/17/19 - 01:03 pm
Tags:
CAR-T
,
MorphoSys
,
Novartis
,
Gilead Sciences
,
tafasitamab
,
DLBCL
Novartis takes another step forward in global Kymriah rollout as Japan OKs the drug at $305K
Endpoints
Wed, 05/15/19 - 10:31 am
Tags:
Novartis
,
Kymriah
,
Japan
,
CAR-T
Novartis' Sandoz does digital from back office to 'not just apps' therapeutics
Fierce Pharma
Tue, 05/14/19 - 05:04 pm
Tags:
digital pharma
,
Sandoz
,
Novartis
Novartis’ Gilenya proves superiority over glatiramer acetate in relapsing remitting MS
Pharmaceutical Business Review
Mon, 05/13/19 - 08:14 pm
Tags:
Novartis
,
Gilenya
,
Relapsing Remitting Multiple Sclerosis
Novartis vows to fight U.S. price-fixing claims against Sandoz unit
Yahoo/Reuters
Mon, 05/13/19 - 09:24 am
Tags:
Novartis
,
Sandoz
,
generics
,
price fixing
Takeda sells Shire’s Xiidra, transfers 400 staffers to Novartis in $3.4B deal
Fierce Pharma
Thu, 05/9/19 - 11:11 am
Tags:
Takeda
,
Shire
,
Novartis
,
M&A
,
Xiidra
,
dry eye disease
Novartis sees Saudi Arabia as promising market for producing its cancer drugs
Fierce Pharma
Thu, 05/9/19 - 11:04 am
Tags:
Novartis
,
oncology
,
cancer
,
Saudi Arabia
Pushing hard for blockbuster returns, Novartis finds PhIII data to assert Mayzent boosts cognitive powers in MS patients
Endpoints
Thu, 05/9/19 - 10:43 am
Tags:
Novartis
,
Mayzent
,
siponimod
,
multiple sclerosis
Novartis Considers Offer for Takeda Eye-Disease Assets
Bloomberg
Wed, 05/8/19 - 05:25 pm
Tags:
Novartis
,
Takeda
,
Shire
,
eye disease
,
M&A
Roche, PTC post latest SMA data from their attempt to rival Spinraza, Zolgensma
Fierce Biotech
Tue, 05/7/19 - 10:19 am
Tags:
Roche
,
PTC Therapeutics
,
spinal muscular atrophy
,
risdiplam
,
Novartis
,
Zolgensma
,
Biogen
,
Spinraza
New Zolgensma data suggest comparable efficacy to Spinraza — analysts
Endpoints
Mon, 05/6/19 - 09:52 pm
Tags:
Novartis
,
FDA
,
spinal muscular atrophy
,
Zolgensma
,
AveXis
,
Biogen
,
Spinraza
FDA Raises Concerns With Novartis in Clinical Inspection
RAPS.org
Mon, 05/6/19 - 07:30 pm
Tags:
Novartis
,
FDA
,
Mayzent
,
siponimod
,
clinical trials
,
multiple sclerosis
Novartis makes final Zolgensma pitch before FDA decision
BioPharma Dive
Sun, 05/5/19 - 06:51 pm
Tags:
Novartis
,
gene therapy
,
Zolgensma
,
FDA
,
spinal muscular atrophy
SMA Moment: Will Gene Therapy Shift Treatment, Costs of Muscle Disease?
Xconomy
Thu, 05/2/19 - 11:00 am
Tags:
gene therapy
,
SMA
,
spinal muscular atrophy
,
Novartis
,
Zolgensma
Can 'synthetic lethality' and deep experience propel this cancer-fighting biotech's $70M IPO?
Bizjournals
Tue, 04/30/19 - 09:37 am
Tags:
Ideaya
,
Novartis
,
IPOs
,
cancer
How a Medicare Rule Change Could Bring CAR-T Stocks Back to Life
Motley Fool
Sat, 04/27/19 - 10:47 am
Tags:
Gilead Sciences
,
Novartis
,
CMS
,
Medicare
,
CAR-T
Pharma Giant Novartis Eyes Better 2019 Profit And 3 New Blockbuster Hopefuls
Investors Business Daily
Wed, 04/24/19 - 12:10 pm
Tags:
Novartis
,
earnings
Pages
« first
‹ previous
…
42
43
44
45
46
47
48
49
50
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.